Relsys International Launches the Pharmacovigilance Integrated Services Offering and Significantly Expands Project Delivery Capabilities
provider of drug safety, pharmacovigilance and risk management solutions,
announces the launch of its Integrated Services Offering for pharmacovigilance
as well as significant growth of its Global Professional Services (GPS)
organization.
In 2008, Relsys has delivered numerous Argus Safety(TM) upgrade projects,
even as it continues to add new system implementations to its portfolio.
Jabbal
organization has increased the number of projects delivered by more than 300%
over 2007, with several more projects due to be completed before the end of
the year.” New safety database implementations in 2008 have included at least
three Top 20 pharma companies, as well numerous smaller and mid-sized
companies. Jabbal continued: “We have proactively scaled our professional
services organization to address the growth in our project portfolio. Our team
has doubled in the past year, as we have hired numerous project managers,
analysts and subject matter experts. The Relsys GPS team has the capacity to
continue to deliver even more new projects in the future.”
Relsys has also launched its Integrated Services Offering, focusing on
delivering pharma projects on-time, to-plan and to-budget. Jabbal commented:
“We have always been focused on delivering end-to-end drug safety solutions to
address our clients’ pharmacovigilance needs. Our primary vision is to
effectively execute the delivery of the Integrated Services Offering to
address pharma’s pressing safety and risk management needs.” To ensure
successful execution, Relsys has also implemented a Services Quality
Management System (SQMS) — a quality assurance system for professional
services with an explicit goal to increase standards of excellence. “We are
very excited about the new programs — they are an integral part of our vision
to become a world-class services organization,” said Jabbal.
Interested parties may learn more about the Integrated Service Offerings
and SQMS by visiting http://www.relsys.net/services or by contacting us at
info@relsys.net.
About Relsys International
Relsys International provides the industry-leading
systems solution for Drug Safety, Pharmacovigilance and Risk Management that
helps pharmaceutical, biotech and medical device companies improve drug safety
and ensure ongoing compliance with global regulations. The company, founded in
1987, works in partnership with its customers to develop and deliver
innovative solutions to long-term business needs, and to provide critical
components to support its clients’ corporate risk management strategies. Argus
Safety(TM), the company’s flagship product, is the world’s widely-used drug
safety and adverse event reporting software. Relsys is a privately held
company, headquartered in
http://www.relsys.net, or call +1 949-453-1715.
SOURCE Relsys International